Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    HER2 Expression in Urothelial Carcinoma (UC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Early Diagnosis Improvement of Chlamydia Infections
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Addressing Healthcare Disparities in the Outpatient Diagnosis and Management of COVID-19
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Treating Older Patients with HR+/HER2- Metastatic Breast Cancer (mBC): Best Practices for Their Assessment and Care
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Treating the Whole Patient: Considerations for Patients with HR+/HER2- Metastatic Breast Cancer (mBC) and Existing Comorbidities
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Optimizing Testing and Treatment in Metastatic Colorectal Cancer (mCRC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Closing the Gaps within Intestinal Ultrasound
    Release Date:
    Partner: International Bowel Ultrasound Group
    Review Process: Expert Review Panel
    Research Inflammation & Immunology All
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Relapsed/Refractory Multiple Myeloma (United States and Western Europe, Japan, Singapore, Canada and Brazil)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Aplastic Anemia - Patient Education and Support (Europe)
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine All
    Review and analysis of retrospective, local source, serotype distribution for invasive pneumococcal disease
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Algeria, Bahrain, Egypt, Iraq, Jordan, Kuwait, Lebanon, Libyan Arab Jamahiriya, Morocco, Oman, Qatar, Saudi Arabia, Tunisia, United Arab Emirates
    Enhance Clinical Research Capacity and Capability in China
    Release Date:
    Review Process: Pfizer Internal
    Education Support for the Professions China
    Optimizing Telemedicine/Telehealth for the Rheumatology Community
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Quality of Care Initiative to Improve the Treatment of Locally Advanced or Metastatic (Stage IV) Bladder Cancer Patients
    Release Date:
    Partner: National Comprehensive Cancer Network, EMD Serono
    Review Process: Expert Review Panel
    Quality Improvement Oncology USA
    Multidisciplinary Gene Therapy Education - Recombinant Adeno-Associated Virus (rAAV)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    Quality Improvement Grants to Support the Delivery of Gene Therapies to Patients with Rare Disease by a Multidisciplinary Team
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease All
    Improving NOAC adherence and persistence, initiatives for pharmacists
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Internal Medicine Israel
    Review and Analysis of Retrospective, Local Source, Serotype Distribution for Invasive Pneumococcal Disease in Latin America
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines All
    Invasive Fungal Infections Research in China
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Addressing Knowledge Gaps in Inflammatory Bowel Disease (IBD) Care
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA